Prof. Xiuwei Chen 陈秀玮
Chief Physician, Professor
Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of gynecologic malignancies, minimally invasive and laparoscopic surgery, transvaginal procedures, hysteroscopic diagnosis, and management of common and complex gynecologic conditions.
Dr. Chen holds a medical doctorate and serves as Chief Physician, Professor, Deputy Department Director, and doctoral supervisor. With over 30 years in clinical practice, teaching, and research, Dr. Chen completed a one-year fellowship in obstetrics and gynecology at the University of Medicine and Dentistry of New Jersey in 2010.
Professional roles
- Standing Committee Member, Heilongjiang Women Physicians Association
- Member, Gynecology Branch, Chinese Preventive Medicine Association
- Standing Committee Member, Obstetrics and Gynecology Branch, Heilongjiang Medical Doctor Association
- Vice Chair, Pelvic Floor Branch, Heilongjiang Medical Association
Name order: in Chinese the family name comes first (Chen Xiuwei). Papers usually list the name as Xiuwei Chen or Chen X.
Selected publications
22 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Med Oncol, 2026 (senior author): DHCR24 promotes endometrial carcinoma progression and is associated with cellular senescence regulation. PubMed 42742784
- Clin Epigenetics, 2026 (senior author): ATAD2 suppresses senescence and SASP via SIRT7-p53/p21 to drive progression and immune evasion in endometrial cancer. PubMed 42324545
- Discov Oncol, 2025 (senior author): DNA methylation and transcription factor-driven immune subtypes in ovarian cancer. PubMed 40875153
- Discov Oncol, 2024 (senior author): miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition. PubMed 38916621
- Pathol Res Pract, 2023 (senior author): Contribution and underlying mechanisms of lncRNA TRPM2-AS in the development and progression of human cancers. PubMed 37871443
- J Ovarian Res, 2022 (senior author): UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer. PubMed 36088429
- Front Genet, 2022 (senior author): Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer. PubMed 36092866
- Mol Omics, 2022 (senior author): KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma. PubMed 35485290
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion